Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on Macrogenics, Raises Price Target to $11

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $10 to $11.
byBenzinga Newsdesk
October 18, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $10 to $11.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

2 High-Yielding Materials Stocks Set To Benefit From Demand For EVs And Semiconductors

By Robert Kuczmarski
August 28, 3:45 PM
The efforts to transition to electric-vehicles are gaining momentum, with states such as California setting new legislation that prohibits the sale of new combustion vehicles by 2035. Additionally, the Science and Chips Act of 2022 will allocate billions of dollars in tax credits for semiconductors companies to build new fabrication facilities.

DOW